TRIPS and the Pharmaceutical Industry in Bangladesh: Towards a National Strategy
AbstractThe paper presents a study of the WTO-Doha Declaration on TRIPS and Public Health and explores the opportunities of the growth of Bangladesh’s domestic pharmaceutical industry. The paper comes up with a number of policy suggestions in terms of designing a national strategy for the development of Bangladesh’s pharmaceutical sector in the context of the Doha Declaration.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by Centre for Policy Dialogue (CPD) in its series CPD Working Paper with number 24.
Length: 44 pages
Date of creation: Apr 2003
Date of revision:
Trade-Related Aspects of Intellectual Property; TRIPS; Pharmaceutical Industry; Bangladesh;
Find related papers by JEL classification:
- L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology
- I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
- O34 - Economic Development, Technological Change, and Growth - - Technological Change; Research and Development; Intellectual Property Rights - - - Intellectual Property and Intellectual Capital
You can help add them by filling out this form.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Avra Bhattacharjee).
If references are entirely missing, you can add them using this form.